International Patent: COMBINATIONS OF INHIBITORS OF ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1 (ENPP1) WITH RADIATION FOR CANCER THERAPY

GENEVA, July 2 -- STINGRAY THERAPEUTICS, INC. filed a patent application (US2025/059650) for “COMBINATIONS OF INHIBITORS OF ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1 (ENPP1) WITH RADIATION FOR CANCER THERAPY”. With publication no. WO/2026/136237, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 239/72

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....